The Nasdaq Composite, fresh off its quickest 10% correction in history (just three sessions!), energetically bounced back Wednesday despite little in the way of fresh drivers.
AstraZeneca (AZN, -1.9%) said late Tuesday that it had to put its COVID-19 vaccine trial on hold when an "adverse reaction" triggered an automatic pause in the study – a common occurrence, but one that raised plenty of eyebrows given the heavy scrutiny on coronavirus-related trials.
Also, the Labor Department reported that new hires fell from 7 million in June to 5.8 million in July, though job openings rose to a higher-than-expected 6.62 million.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The major indices powered ahead nonetheless. Big moves in Apple (AAPL, +4.0%), Microsoft (MSFT, +4.3%) and other tech stocks pushed the Nasdaq 2.7% higher to 11,141.
Other action in the stock market today:
- The Dow Jones Industrial Average finished 1.6% higher to 27,940.
- The S&P 500 gained 2.0% to close at 3,398.
- The Russell 2000 climbed 1.5% to 1,528.
- Lululemon Athletica (LULU, -7.4%) plunged despite a big earnings beat of 74 cents per share (versus 55 cents per share expected) and 2% revenue growth that surprised analysts, who were looking for quarterly sales to decline.
- Slack Technologies (WORK, -13.9%) suffered one of its worst single-day losses since its June 2019 initial public offering despite beating both official top- and bottom-line expectations for the quarter. Wedbush’s Daniel Ives, who rates WORK at Underperform, says, “The main focus of investors this morning will be Slack's billings miss with the company surprisingly missing expectations which will be a shock to the bulls anticipating a clean beat.”
Beware a Dead-Cat Bounce?
So what sent stocks soaring on Wednesday? You could argue that any setbacks on the vaccine front are a boon for tech stocks, as cloud companies, e-commerce firms and other work-from-home picks directly benefit from Americans continuing to have to do more digitally.
But the rally was more than just tech – every sector was in the black today.
As we pointed out in our free A Step Ahead email newsletter, the market might have just sold off too far too fast.
"The continuation of last week's sell off into the new week has pushed U.S. equities into oversold territory on a short-term basis," writes Dan Wantrobski, technical strategist at Janney Montgomery Scott. "While short-term conditions indicate a potential bounce/oversold rally ahead, we believe there may be more to this corrective cycle ahead.
"This is because recent leadership areas remain very overbought on the longer-term charts – even after the last few days. This implies we could see further consolidation efforts in the weeks ahead as we make our way through September and toward elections."
As we said to start September, this month could be a wild one. For some, that means playing defense, but keep your wish list handy, too – you never know when a quick market dip can provide better values on some of Wall Street's top stocks. That could include these 20 income-rich retirement plays, which are built to last for decades.
Kyle Woodley was long MSFT as of this writing.
-
The Most Popular Apps for Retirement Planning in 2025A J.D. Power survey ranks retirement planning apps based on customer service and satisfaction. Does your financial app make the cut?
-
Don't Disinherit Your Grandchildren: The Hidden Risks of Retirement Account Beneficiary FormsStandard retirement account beneficiary forms may not be flexible enough to ensure your money passes to family members according to your wishes. Naming a trust as the contingent beneficiary can help avoid these issues. Here's how.
-
S&P 500 Hits New High After Oracle Earnings: Stock Market TodayAnother down day for Apple held the Dow Jones Industrial Average back, though.
-
Stocks Grind Up to New All-Time Highs: Stock Market TodayUnitedHealth stock led the Dow Jones Industrial Average amid increasing signs the labor market has not been well for months.
-
Markets Prepare for August Inflation Data: Stock Market TodayApple CEO Tim Cook is still important, but price action this week is as much about incoming inflation data ahead of next week's Fed meeting.
-
Stocks Slip as Job Growth Stalls: Stock Market TodayThe August jobs report came in much weaker than expected, while the unemployment rate ticked higher.
-
Big Tech Names Rise Above Broad Weakness: Stock Market TodaySome familiar names enjoyed solid rallies on the resolution of outstanding questions, but macro uncertainty hangs over the broader market.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
-
Dow Rips 846 Points to New All-Time High: Stock Market TodayFed Chair Jerome Powell seems ready to cut interest rates in the fall but will still rely on incoming economic data about inflation and employment.
